Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 329-332, June 2006

How good is allogeneic transplantation for high-risk patients with AML?

  • Hans A. Messner, MD (Professor of Medicine, Director BMT Program)

      Affiliations

    • Corresponding Author InformationTel.: +1 4169462266; fax: +1 4169466485.

University Health Network, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Toronto, Ont., Canada M5G 2M9

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-6926(05)00109-X

doi:10.1016/j.beha.2005.11.007

Best Practice & Research Clinical Haematology
Volume 19, Issue 2 , Pages 329-332, June 2006

Article Tools